comparemela.com
Home
Live Updates
ProstACT SELECT Study of TLX591 Interim Readout: Positive Results Confirm Safety and Tolerability : comparemela.com
ProstACT SELECT Study of TLX591 Interim Readout: Positive Results Confirm Safety and Tolerability
/PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces positive preliminary results from the Phase I ProstACT SELECT...
Related Keywords
New York ,
United States ,
Brazil ,
Japan ,
Canada ,
Switzerland ,
United Kingdom ,
Belgium ,
Australia ,
Melbourne ,
Victoria ,
Australian ,
Kyahn Williamson ,
Nat Lenzo ,
Colin Hayward ,
Scottt Tagawa ,
Corporate Communications ,
Drug Administration ,
Telix Pharmaceuticals ,
Australian Therapeutic Goods Administration ,
Prnewswire Telix Pharmaceuticals Limited ,
Health Canada ,
Genesiscare Group Clinical ,
Telix Pharmaceuticals Limited Disclosure Committee ,
Australian Securities Exchange ,
European Union ,
Pharmaceuticals Limited ,
Genesiscare Group Clinical Director Theranostics ,
Telix Chief Medical Officer ,
Marketing Authorisation Applications ,
Telix Pharmaceuticals Limited ,
comparemela.com © 2020. All Rights Reserved.